Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Consulting agrmnt
Director departure
|
|
Ampio Pharmaceuticals, Inc. (AMPE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2011 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 03/25/2011 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 01/07/2011 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 01/06/2011 |
8-K/A
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Ampio Acquisition, Inc., a wholly-owned subsidiary of the Company, DMI BioSciences, Inc. (“BioSciences”), and the control shareholders of BioSciences",
"Donation to Capital Agreement, to be effective immediately prior to closing of the Merger, among BioSciences and its management shareholders",
"Form of Indemnification Escrow Agreement, to be effective upon closing of the Merger, among the Company, Ampio Acquisition, Inc., BioSciences, the BioSciences control shareholders, and Corporate Stock Transfer, Inc., as Escrow Agent",
"Form of Cancellation Agreement, to be effective immediately prior to closing of the Merger, among BioSciences and members of BioSciences management",
"Form of Conversion Agreement, to be effective immediately prior to closing of the Merger, among BioSciences and Richard Yukl and IRA for Richard Yukl" |
|
| 08/16/2010 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 03/17/2010 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|